{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:39:01Z","timestamp":1781721541774,"version":"3.54.5"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["EP\/L016044\/1"],"award-info":[{"award-number":["EP\/L016044\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline plc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015660","name":"UCB Celltech","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015660","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Therapeutic Structural Antibody Database (Thera-SAbDab; http:\/\/opig.stats.ox.ac.uk\/webapps\/therasabdab) tracks all antibody- and nanobody-related therapeutics recognized by the World Health Organisation (WHO), and identifies any corresponding structures in the Structural Antibody Database (SAbDab) with near-exact or exact variable domain sequence matches. Thera-SAbDab is synchronized with SAbDab to update weekly, reflecting new Protein Data Bank entries and the availability of new sequence data published by the WHO. Each therapeutic summary page lists structural coverage (with links to the appropriate SAbDab entries), alignments showing where any near-matches deviate in sequence, and accompanying metadata, such as intended target and investigated conditions. Thera-SAbDab can be queried by therapeutic name, by a combination of metadata, or by variable domain sequence - returning all therapeutics that are within a specified sequence identity over a specified region of the query. The sequences of all therapeutics listed in Thera-SAbDab (461 unique molecules, as of 5\u00a0August 2019) are downloadable as a single file with accompanying metadata.<\/jats:p>","DOI":"10.1093\/nar\/gkz827","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:09:35Z","timestamp":1569377375000},"page":"D383-D388","source":"Crossref","is-referenced-by-count":201,"title":["Thera-SAbDab: the Therapeutic Structural Antibody Database"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-5297","authenticated-orcid":false,"given":"Matthew I J","family":"Raybould","sequence":"first","affiliation":[{"name":"Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles\u2019, Oxford OX1 3LB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5931-2437","authenticated-orcid":false,"given":"Claire","family":"Marks","sequence":"additional","affiliation":[{"name":"Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles\u2019, Oxford OX1 3LB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P","family":"Lewis","sequence":"additional","affiliation":[{"name":"Data and Computational Sciences, GlaxoSmithKline Research and Development, Gunnels Wood Road, Stevenage SG1 2NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-8680","authenticated-orcid":false,"given":"Jiye","family":"Shi","sequence":"additional","affiliation":[{"name":"Chemistry Department, UCB Pharma, 216 Bath Road, Slough SL1 3WE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bujotzek","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, DE-82377 Penzberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-4978","authenticated-orcid":false,"given":"Bruck","family":"Taddese","sequence":"additional","affiliation":[{"name":"Discovery Sciences Department, AstraZeneca, Granta Park, Cambridge CB21 6GH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-2252","authenticated-orcid":false,"given":"Charlotte M","family":"Deane","sequence":"additional","affiliation":[{"name":"Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles\u2019, Oxford OX1 3LB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"2020010521382875800_B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","article-title":"The increasingly human and profitable monoclonal antibody market","volume":"37","author":"Grilo","year":"2018","journal-title":"Trends Biotechnol."},{"key":"2020010521382875800_B2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","article-title":"Nanobodies as therapeutics: big opportunities for small antibodies","volume":"21","author":"Steeland","year":"2017","journal-title":"Drug Discov. Today"},{"key":"2020010521382875800_B3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/19420862.2018.1556465","article-title":"Antibodies to watch in 2019","volume":"11","author":"Kaplon","year":"2019","journal-title":"mAbs"},{"key":"2020010521382875800_B4","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-61779-931-0_15","article-title":"PEGylation of Antibody Fragments for Half-Life Extension","volume-title":"Antibody Methods and Protocols. Methods in Molecular Biology (Methods and Protocols)","author":"Jev\u0161evar","year":"2012"},{"key":"2020010521382875800_B5","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-11-0483","article-title":"Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends","volume":"17","author":"Steiner","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"2020010521382875800_B6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020010521382875800_B7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat. Rev. Drug Disc."},{"key":"2020010521382875800_B8","first-page":"559","article-title":"Proposed International Nonproprietary Names (INN) List 120","volume":"32","author":"WHO","year":"2018","journal-title":"WHO Drug Information"},{"key":"2020010521382875800_B9","first-page":"59","article-title":"Recommended International Nonproprietary Names (INN) List 81","volume":"33","author":"WHO","year":"2019","journal-title":"WHO Drug Information"},{"key":"2020010521382875800_B10","first-page":"470b","article-title":"IMGT\/mAb-DB: the IMGT database for therapeutic monoclonal antibodies","volume":"13","author":"Poiron","year":"2010","journal-title":"JOBIM 2010"},{"key":"2020010521382875800_B11","first-page":"gkz714","article-title":"The ABCD database: a repository for chemically defined antibodies","volume":"48","author":"Lima","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2020010521382875800_B12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/EBC20170052","article-title":"Structure-based drug design: aiming for a perfect fit","volume":"61","author":"van\u00a0Montfont","year":"2017","journal-title":"Essays Biochem"},{"key":"2020010521382875800_B13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1039\/C9ME00034H","article-title":"Antibody-antigen complex modelling in the era of immunoglobulin repertoire sequencing","volume":"4","author":"Raybould","year":"2019","journal-title":"Mol. Syst. Des. Eng."},{"key":"2020010521382875800_B14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cbdd.13388","article-title":"Homology modeling in drug discovery: overview, current applications, and future perspectives","volume":"93","author":"Muhammed","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"2020010521382875800_B15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"2020010521382875800_B16","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: the structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2020010521382875800_B17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"key":"2020010521382875800_B18","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2020010521382875800_B19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1006\/jmbi.1997.1354","article-title":"Standard conformations for the canonical structures of immunoglobulins","volume":"273","author":"Al-Lazikani","year":"1997","journal-title":"J. Mol. Biol."},{"key":"2020010521382875800_B20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/19420862.2019.1624463","article-title":"Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease","volume":"11","author":"Benschop","year":"2019","journal-title":"mAbs"},{"key":"2020010521382875800_B21","doi-asserted-by":"crossref","first-page":"W474","DOI":"10.1093\/nar\/gkw361","article-title":"SAbPred: a structure-based antibody prediction server","volume":"44","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2020010521382875800_B22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/19420862.2016.1205773","article-title":"ABodyBuilder: automated antibody structure prediction with data-driven accuracy estimation","volume":"8","author":"Leem","year":"2016","journal-title":"mAbs"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/48\/D1\/D383\/31697697\/gkz827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/48\/D1\/D383\/31697697\/gkz827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:58:39Z","timestamp":1695229119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/48\/D1\/D383\/5573951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":22,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2019,9,26]]},"published-print":{"date-parts":[[2020,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkz827","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/707521","asserted-by":"object"}]},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1,8]]},"published":{"date-parts":[[2019,9,26]]}}}